Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, Connecticut
- Most recent report
- 8-K, filed Oct 19, 2026
- Incorporated
- Delaware
- Filings on record
- 97 filings
- On EDGAR
- CIK 1827635
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 3
News 8 of 9
Prospectuses and Registrations 8 of 11
- 424B3 Prospectus supplement for an offering Aug 14, 2026
- S-1 Registration statement for an offering Aug 7, 2026
- 424B4 Final prospectus for an offering Apr 30, 2026
- FWP Free writing prospectus Apr 30, 2026
- FWP Free writing prospectus Apr 27, 2026
- S-1 Registration statement for an offering Apr 27, 2026
- S-8 Registration statement for an employee plan Feb 5, 2026
- 424B4 Final prospectus for an offering Feb 4, 2026
Ownership 8 of 55
- SCHEDULE 13G Large holder reported a passive stake Oct 13, 2026
- 4 Insider reported a trade Sep 3, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 3 Insider reported their initial holding Aug 20, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 4 Insider reported a trade Aug 18, 2026
Other 8 of 19
- EFFECT Notice that a registration became effective Aug 14, 2026
- D May 15, 2026
- EFFECT Notice that a registration became effective Apr 29, 2026
- S-1MEF Apr 29, 2026
- CORRESP Reply to SEC staff Apr 27, 2026
- CORRESP Reply to SEC staff Apr 27, 2026
- UPLOAD Comment letter from SEC staff Apr 7, 2026
- DRS Draft registration statement, submitted confidentially Apr 6, 2026
Everything here comes from Veradermics, Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.